Table 2 Reporting odds ratio of fall-related adverse events
Drug | Case | Total | Reporting Ratio (%) | ROR (95% CI) |
|---|---|---|---|---|
Total | 3715 | 430,587 | Â | Â |
Alpha-adrenoreceptor antagonists | 64 | 4600 | 1.39 | 1.63 (1.27–2.09) |
Sulfonamides, plain/Aryloxyacetic acid derivatives | 162 | 25,016 | 0.65 | 0.74 (0.63–0.86) |
Calcium channel blockers | 542 | 51,482 | 1.05 | 1.26 (1.15–1.38) |
Opioids | 189 | 23,530 | 0.80 | 0.93 (0.80–1.07) |
Benzodiazepine derivatives/Benzodiazepine related drugs | 561 | 38,300 | 1.46 | 1.83 (1.68–2.01) |
Barbiturates, plain, Aldehydes, Melatonin receptor agonists, and other hypnotics and sedatives | 38 | 2865 | 1.33 | 1.55 (1.12–2.14) |
Non-selective monoamine reuptake inhibitors | 68 | 3479 | 1.95 | 2.31 (1.82–2.95) |
Selective serotonin reuptake inhibitors | 212 | 9058 | 2.34 | 2.86 (2.49–3.29) |